Oncology/Hematology market research reports by GlobalData

• Thematic Intelligence - Biosimilars in oncology

  Dec 29, 2023  |  Published by: GlobalData  |  USD 7,995

  Thematic Intelligence - Biosimilars in oncology Summary Clients will gain insight into the percentage of cancer patients treated with biosimilars, the price of these agents compared to their originator, and key opinion leaders’ outlook for the products. The report includes the 8MM regulatory landsca ... Read More

• Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) - Global Clinical Trials Review, 2023

  Dec 20, 2023  |  Published by: GlobalData  |  USD 2,500

  Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update pro ... Read More

• Gallbladder Cancer - Global Clinical Trials Review, 2023

  Dec 20, 2023  |  Published by: GlobalData  |  USD 2,500

  Gallbladder Cancer - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Gallbladder Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Gallbladder Cancer Clinical trials scenario. This report pr ... Read More

• Hepatocellular Carcinoma - Global Clinical Trials Review, 2023

  Dec 20, 2023  |  Published by: GlobalData  |  USD 2,500

  Hepatocellular Carcinoma - Global Clinical Trials Review, 2023 Summary GlobalData's clinical trial report, “Hepatocellular Carcinoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update provides an overview of Hepatocellular Carcinoma Clinical trials scenar ... Read More

• Anal Cancer (AC) - Competitive Landscape

  Dec 06, 2023  |  Published by: GlobalData  |  USD 3,495

  Anal Cancer (AC) - Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in AC therapeutics. More than 33,000 diagnosed incident cases of AC are anticipated in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast ... Read More

• Digital Marketing Trends in Non-small Cell Lung Cancer

  Nov 30, 2023  |  Published by: GlobalData  |  USD 1,950

  Digital Marketing Trends in Non-small Cell Lung Cancer Summary Merck’s Keytruda.com achieved the highest total traffic across non-small cell lung cancer (NSCLC) patient sites in the US, with over 2.4 million visitors from October 2022 to September 2023. This was followed by BMS's Opdivo.com (1.7 mil ... Read More

• Colorectal Cancer Screening Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

  Nov 28, 2023  |  Published by: GlobalData  |  USD 4,000

  Colorectal Cancer Screening Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies Summary GlobalData's Medical Devices sector report, “Colorectal Cancer Screening Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory ... Read More

• Cervical Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  Nov 21, 2023  |  Published by: GlobalData  |  USD 2,500

  Cervical Cancer Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Cervical Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 U ... Read More

• Ewing Sarcoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  Oct 24, 2023  |  Published by: GlobalData  |  USD 2,500

  Ewing Sarcoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Ewing Sarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Updat ... Read More

• Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  Oct 24, 2023  |  Published by: GlobalData  |  USD 2,500

  Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update Summary GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Clinical Trial Analysis by Trial ... Read More

• Digital Marketing Trends in Colorectal Cancer

  Sep 30, 2023  |  Published by: GlobalData  |  USD 1,950

  Digital Marketing Trends in Colorectal Cancer Summary Merck’s Keytruda.com achieved the highest total traffic across CRC patient sites in the US, with over 3.3 million visitors from August 2022 to July 2023. This was followed by BMS’s Opdivo.com (1.7 million visits) and Roche’s Avastin.com (258,000 ... Read More

• Chronic Lymphocytic Leukemia (CLL) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032

  Sep 29, 2023  |  Published by: GlobalData  |  USD 9,995

  Chronic Lymphocytic Leukemia (CLL) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032 Summary This report covers the 7MM (US, France, Germany, Italy, Spain, UK, and Japan) and includes an assessment of the disease epidemiology and 10-year patient-based for ... Read More

• Acute Myeloid Leukemia (AML) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032

  Sep 29, 2023  |  Published by: GlobalData  |  USD 9,995

  Acute Myeloid Leukemia (AML) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032 Summary This report covers the 8MM (US, France, Germany, Italy, Spain, UK, Japan, and China) and includes an assessment of the disease epidemiology and 10-year patient-based fo ... Read More

• Diffuse Large B-Cell Lymphoma (DLBCL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  Aug 21, 2023  |  Published by: GlobalData  |  USD 3,495

  Diffuse Large B-Cell Lymphoma (DLBCL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in DLBCL therapeutics. More than 555,000 diagnosed prevalent cases of DLBCL are ... Read More

• Cutaneous Squamous Cell Carcinoma (cSCC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  Aug 10, 2023  |  Published by: GlobalData  |  USD 3,495

  Cutaneous Squamous Cell Carcinoma (cSCC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in cSCC therapeutics. More than 16 million diagnosed prevalent cases of DN a ... Read More

• Ewing Sarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  Jun 30, 2023  |  Published by: GlobalData  |  USD 3,495

  Ewing Sarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Ewing Sarcoma therapeutics. There will be only 9,457 diagnosed prevalent cases of ES in 2023 in the ... Read More

• Colorectal Cancer Screening Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033

  Jun 22, 2023  |  Published by: GlobalData  |  USD 7,500

  Colorectal Cancer Screening Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033 Summary Colorectal Cancer Screening Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analy ... Read More

• Hematology Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033

  Jun 19, 2023  |  Published by: GlobalData  |  USD 7,500

  Hematology Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033 Summary Hematology Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to vis ... Read More

• Muscle Invasive Bladder Cancer (MIBC) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  May 30, 2023  |  Published by: GlobalData  |  USD 2,500

  Muscle Invasive Bladder Cancer (MIBC) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Muscle Invasive Bladder Cancer Clinical Trial Analysis by Trial Phase, Trial Status, ... Read More

• Multiple Myeloma (Kahler Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  May 30, 2023  |  Published by: GlobalData  |  USD 2,500

  Multiple Myeloma (Kahler Disease) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Multiple Myeloma (Kahler Disease) Clinical Trial Analysis by Trial Phase, Trial Status, T ... Read More

• Immuno-Oncology (IO) - Thematic Intelligence

  May 12, 2023  |  Published by: GlobalData  |  USD 7,995

  Immuno-Oncology (IO) - Thematic Intelligence Summary This report includes coverage of immuno-oncology overview, trends, value chain, leading marketed and pipeline products, market analysis, regulatory landscape and market access, opportunities, challenges, and unmet needs, commercial assessment - ma ... Read More

• India Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030

  Apr 28, 2023  |  Published by: GlobalData  |  USD 2,995

  India Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summary ... Read More

• United States of America (USA) Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030

  Apr 28, 2023  |  Published by: GlobalData  |  USD 2,995

  United States of America (USA) Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and ... Read More

• Russia Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030

  Apr 28, 2023  |  Published by: GlobalData  |  USD 2,995

  Russia Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summar ... Read More

• Spain Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibr

  Apr 28, 2023  |  Published by: GlobalData  |  USD 2,995

  Spain Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summary ... Read More

< prev 1 2 3 4 5 next >